Intensive care unit delirium

Critical Care Nursing Quarterly

Volumn 36, Issue 4, 2013, Pages 370-389

  Desai, Sapana ^a   Chau, Terence ^a   George, Liza ^a  

^a MEMORIAL HERMANN HOSPITAL   (United States)

Author keywords

Delirium; Intensive care unit; Prevention; Risk factors; Treatment

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DEXMEDETOMIDINE; HALOPERIDOL; LORAZEPAM; MIDAZOLAM; OLANZAPINE; OPIATE; PLACEBO; PROPOFOL; QUETIAPINE; RISPERIDONE; RIVASTIGMINE; ZIPRASIDONE;

ALCOHOL ABUSE; ARTICLE; ARTIFICIAL VENTILATION; BRADYCARDIA; COGNITIVE DEFECT; COMA; COMPARATIVE STUDY; CONSTIPATION; CRITICALLY ILL PATIENT; DELIRIUM; DRUG DOSE COMPARISON; EXTRAPYRAMIDAL SYMPTOM; HOSPITAL PATIENT; HUMAN; HYPOTENSION; INTENSIVE CARE PSYCHOSIS; INTENSIVE CARE UNIT; LENGTH OF STAY; METABOLIC ACIDOSIS; MORTALITY; NEUROLEPTIC MALIGNANT SYNDROME; OCCUPATIONAL THERAPY; PROLACTIN BLOOD LEVEL; PROPOFOL INFUSION SYNDROME; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RISK FACTOR; SEDATION; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; VENTILATED PATIENT; WEIGHT GAIN; XEROSTOMIA;

ANTIPSYCHOTIC AGENTS; DELIRIUM; HUMANS; INTENSIVE CARE;

EID: 84884268093     PISSN: 08879303     EISSN: 15505111     Source Type: Journal    
DOI: 10.1097/CNQ.0b013e3182a10e8e     Document Type: Article

References (66)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Publishing, Inc; 2013.
2. Inouye SK, Zhang Y, Han L, Leo-Summers L, Jones R, Marcantonio E. Recoverable cognitive dysfunction at hospital admission in older persons during acute illness. J Gen Intern Med. 2006;21(12): 1276-1281.
3. Meagher D, Trzepacz PT. Phenomenological distinctions needed in DSM-V: delirium, subsyndromal delirium, and dementias. J Neuropsychiatry Clin Neurosci. 2007;19(4): 468-470.
4. Peterson JF, Pun BT, Dittus RS, et al. Delirium and its motoric subtypes: a study of 614 critically ill patients. J Am Geriatr Soc. 2006;54(3): 479-484.
5. Ely EW, Truman B, Shintani A, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA. 2003;289(22): 2983-2991.
6. Francis J, Martin D, Kapoor WN. A prospective study of delirium in hospitalized elderly. JAMA. 1990;263(8): 1097-1101.
7. Inouye SK, Bogardus ST, Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. New Engl J Med. 1999; 340(9): 669-676.
8. Levkoff SE, Evans DA, Liptzin B, et al. Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients. Arch Intern Med. 1992;152(2): 334-340.
9. Ely EW, Shintani A, Truman B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004;291(14): 1753-1762.
10. Ouimet S, Kavanagh BP, Gottfried SB, Skrobik Y. Incidence, risk factors and consequences of ICU delirium. Intensive Care Med. 2007;33(1): 66-73.
11. Pisani MA, Murphy TE, Van Ness PH, Araujo KL, Inouye SK. Characteristics associated with delirium in older patients in a medical intensive care unit. Arch Intern Med. 2007;167(15): 1629-1634.
12. Pandharipande P, Cotton BA, Shintani A, et al. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma. 2008;65(1): 34-41.
13. Thomason JW, Shintani A, Peterson JF, Pun BT, Jackson JC, Ely EW. Intensive care unit delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilated patients. Crit Care. 2005;9(4):R375-R381.
14. Pisani MA, Murphy TE, Araujo KL, Slattum P, Van Ness PH, Inouye SK. Benzodiazepine and opioid use and the duration of intensive care unit delirium in an older population. Crit Care Med. 2009;37(1): 177-183.
15. Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the Confusion Assessment Method. A new method for detection of delirium. Ann Intern Med. 1990;113(12): 941-948.
16. Trzepacz PT, Baker RW, Greenhouse J. A symptom rating scale for delirium. Psychiatry Res. 1988;23(1): 89-97.
17. Breitbart W, Rosenfeld B, Roth A, Smith MJ, Cohen K, Passik S. The memorial delirium assessment scale. J Pain Symptom Manage. 1997;13(3): 128-137.
18. Hart RP, Levenson JL, Sessler CN, Best AM, Schwartz SM, Rutherford LE. Validation of a Cognitive Test for Delirium in medical ICU patients. Psychosomatics. 1996;37(6): 533-546.
19. Hart RP, Best AM, Sessler CN, Levenson JL. Abbreviated Cognitive Test for Delirium. J Psychosom Res. 1997;43(4): 417-423.
20. Ely EW, Margolin R, Francis J, et al. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med. 2001;29(7): 1370-1379.
21. Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med. 2001;27(5): 859-864.
22. Csokasy J. Assessment of acute confusion: use of the NEECHAM Confusion Scale. Appl Nurs Res. 1999;12(1): 51-55.
23. Immers HE, Schuurmans MJ, van de Bijl JJ. Recognition of delirium in ICU patients: a diagnostic study of the NEECHAM confusion scale in ICU patients. BMC Nurs. 2005;4: 7.
24. Otter H, Martin J, Basell K, et al. Validity and reliability of the DDS for severity of delirium in the ICU. Neurocrit Care. 2005;2(2): 150-158.
25. Devlin JW, Fong JJ, Fraser GL, Riker RR. Delirium assessment in the critically ill. Intensive Care Med. 2007;33(6): 929-940.
26. Ely EW, Gautam S, Margolin R, et al. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med. 2001;27(12): 1892-1900.
27. Pisani MA, Kong SY, Kasl SV, Murphy TE, Araujo KL, Van Ness PH. Days of delirium are associated with 1- year mortality in an older intensive care unit population. Am J Respir Crit Care Med. 2009;180(11): 1092-1097.
28. Shehabi Y, Riker RR, Bokesch PM, et al. Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients. Crit Care Med. 2010;38(12): 2311-2318.
29. Rothenhäusler HB, Ehrentraut S, Stoll C, Schelling G, Kapfhammer HP. The relationship between cognitive performance and employment and health status in long-term survivors of the acute respiratory distress syndrome: results of an exploratory study. Gen Hosp Psychiatry. 2001;23(2): 90-96.
30. Phillips-Bute B, Mathew JP, Blumenthal JA, et al. Association of neurocognitive function and quality of life 1 year after coronary artery bypass graft (CABG) surgery. Psychosom Med. 2006;68(3): 369-375.
31. Girard TD, Jackson JC, Pandharipande PP, et al. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med. 2010;38(7): 1513-1520.
32. Hopkins RO, Jackson JC. Long-term neurocognitive function after critical illness. Chest. 2006;130(3): 869-878.
33. Marcantonio ER, Kiely DK, Simon SE, et al. Outcomes of older people admitted to postacute facilities with delirium. J Am Geriatr Soc. 2005;53(6): 963-969.
34. Milbrandt EB, Deppen S, Harrison PL, et al. Costs associated with delirium in mechanically ventilated patients. Crit Care Med. 2004;32(4): 955-962.
35. Franco K, Litaker D, Locala J, Bronson D. The cost of delirium in the surgical patient. Psychosomatics. 2001;42(1): 68-73.
36. McNicoll L, Pisani MA, Zhang Y, Ely EW, Siegel MD, Inouye SK. Delirium in the intensive care unit: occurrence and clinical course in older patients. J Am Geriatr Soc. 2003;51(5): 591-598.
37. Van Rompaey B, Elseviers MM, Schuurmans MJ, Shortridge-Baggett LM, Truijen S, Bossaert L. Risk factors for delirium in intensive care patients: a prospective cohort study. Crit Care. 2009;13(3):R77.
38. Dubois MJ, Bergeron N, Dumont M, Dial S, Skrobik Y. Delirium in an intensive care unit: a study of risk factors. Intensive Care Med. 2001;27(8): 1297-1304.
39. Pandharipande P, Shintani A, Peterson J, et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology. 2006;104(1): 21-26.
40. Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007;298(22): 2644-2253.
41. Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA. 2009;301(5): 489-499.
42. Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet. 2009;373(9678): 1874-1882.
43. Lin SM, Huang CD, Liu CY, et al. Risk factors for the development of early-onset delirium and the subsequent clinical outcome in mechanically ventilated patients. J Crit Care. 2008;23(3): 372-379.
44. AldemirM, Ozen S, Kara IH, Sir A, Baç B. Predisposing factors for delirium in the surgical intensive care unit. Crit Care. 2001;5(5): 265-270.
45. Skrobik Y. Delirium prevention and treatment. Crit Care Clin. 2009;25: 585-591.
46. Banh H. Management of delirium in adult critically ill patients: an overview. J Pharm Pharm Sci. 2012;15(4): 449-509.
47. Vasilevskis E, Ely E, Speroff T, Pun B, Boehm L, Dittus R. Reducing Iatrogenic Risks. Chest. 2010;138(5): 1224-1233.
48. Hooper M, Girard T. Sedation and weaning from mechanical ventilation: linking spontaneous awakening trials and spontaneous breathing trials to improve patient outcomes. Crit Care Clin. 2009;25: 515-525.
49. Jakob S, Ruokonen E, Grounds R, et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation. JAMA. 2012; 307(11): 1151-1160.
50. Girard T, Kress J, Thomason DB, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (awakening and breathing controlled trial): a randomised controlled trial. Lancet. 2008;371: 126-134.
51. Devlin J, Roberts R. Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol, and opioids. Crit Care Clin. 2009;25: 431-449.
52. Panzer O, Moitra V, Sladen R. Pharmacology of sedative-analgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral mu antagonists. Crit Care Clin. 2009; 25: 451-469.
53. Lexi-Comp Online. Lexi-Drugs Online. Hudson, OH: Lexi-Comp Inc; 2013. http://online.lexi.com. Accessed January 2, 2013.
54. Elsevier Gold Standard. Clinical Pharmacology Online. Tampa, FL: Gold Standard Inc; 2013. http://www.clinicalpharmacology.com. Accessed January 2, 2013.
55. Barr J, Fraser G, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit: executive summary. Am J Health Syst Pharm. 2013;70: 53-58.
56. Devabhakthuni S, Armahizer M, Dasta J, Kane-Gill S. Analgosedation: a paradigm shift in intensive care unit sedation practice. Ann Pharmacother. 2012;46: 530-540.
57. DiPiro J, Talbert R, Yee G, Matzke G, Wells B, Posey L. Pharmacotherapy: A Pathophysiologic Approach. New York, NY: McGraw-Hill; 2005.
58. Devlin J, Skrobik Y. Antipsychotics for the prevention and treatment of delirium in the intensive care unit: what is their role? Harv Rev Psychiatry. 2011;19(2): 59-67.
59. Girard T, Pandharipande P, Carson S, et al. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebocontrolled trial. Crit Care Med. 2010;38(2): 428-437.
60. Devlin J, Roberts R, Fong J, et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, doubleblind, placebo-controlled pilot study. Crit Care Med. 2010;38(2): 419-427.
61. Skrobik Y, Bergeron N, Dumont M, Gottfried S. Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med. 2004;30: 444-449.
62. Van Eijk M, Roes K, Honing M, et al. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial. Lancet. 2010;376: 1829-1837.
63. Han C, Kim Y. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics. 2004;45(4): 297-301.
64. Reade M, O'Sullivan K, Bates S, Goldsmith D, Ainslie W, Bellomo R. Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial. Crit Care. 2009;13:R75. doi: 10.1186/cc7890.
65. Wang P, Schneeweiss P, Avorn J, et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. New Engl J Med. 2005;353(22): 2335-2341.
66. Lee P, Gill S, Freedman M, Bronskill S, Hillmer M, Rochon P. Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review [published online ahead of print June 11, 2004]. BMJ. 2004;329(7457): 75. doi: 10.1136/bmj.38125.465579.55.